Engineered transition metal catalysts enhance peptide self-assembly, facilitating cell-cell crosstalk detection.
This work reports a robust and versatile strategy for harnessing cell-compatible transition metal catalysts to tune peptide self-assembly precisely in living cells. The engineered cell-compatible Ru catalyst targets cell membranes by chemically tagging membrane-affinity groups and functionalizing the surfaces of living mammalian cells. The anchored Ru catalyst on the cell surface can then recognize the designed substrate and induce the self-assembly of peptides in situ through olefin metathesis. Labeling the CD8+ T cells and cancer cells orthogonally with the Ru catalyst and peptide substrate can detect the molecular transfer from cancer to immune cells. This work, for the first time, provides a general approach and a versatile technology for generating artificial structures of peptides by abiotic catalysts in living cells.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: